Anthrax Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 70 pages | ID: A212B6F7E7C3EN
VPAResearch

Abstracts

Anthrax Drug pipeline report- 2020 is an annual R&D review of Anthrax pipeline candidates. The report presents the current status of all major Anthrax therapeutic compounds. Detailed insights into Anthrax pipeline development, current status, companies, drug profiles and Anthrax preclinical and clinical trials are included.

2020 Anthrax Pipeline Market Insights
Anthrax disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Anthrax therapies, pipeline by phase and others are included.

Anthrax pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Anthrax Therapeutic Drug candidates
Both active and inactive Anthrax pipeline drug candidates are included in the report

Anthrax Clinical Trials and preclinical Studies
Anthrax In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Anthrax pipeline market developments
Anthrax Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Anthrax pipeline companies in active development
The report analyzes Anthrax pipeline of the below companies-

Altimmune Inc, Aphios Corp, Aradigm Corp, BlueWillow Biologics, ContraFect corp, Crestone Inc, Dynavax Technologies Corp , Elusys Therapeutics Inc , Emergent BioSolutions Inc , GC Pharma, Greffex Inc, Hawaii Biotech Inc, iBio Inc, Innovative Biologics Inc, iNtRON Biotechnology Inc, Paratek Pharmaceuticals Inc, Pfenex Inc, Protein Potential LLC, ProThera Biologics Inc, Q BioMed Inc, Soligenix Inc, Tetraphase Pharmaceuticals Inc, Vast Therapeutics Inc, Venomyx Inc, VLP Biotech Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
25 Companies investing in Anthrax pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Anthrax pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. ANTHRAX PIPELINE MARKET INSIGHTS, 2020

1.1 Anthrax Disease Overview
1.2 Anthrax Drug Pipeline Snapshot, 2020
  1.2.1 Anthrax Pipeline Drugs by Phase
  1.2.2 Anthrax Pipeline Drugs by Company
  1.2.3 Anthrax Pipeline Drugs by Mechanism of Action
  1.2.4 Anthrax Pipeline Drugs by Route of Administration

2. ANTHRAX COMPANY WISE PIPELINE DETAILS

Altimmune Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Aphios Corp Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Aradigm Corp Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
BlueWillow Biologics Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
ContraFect corp Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Crestone Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Dynavax Technologies Corp Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Elusys Therapeutics Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Emergent BioSolutions Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
GC Pharma Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Greffex Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Hawaii Biotech Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
iBio Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Innovative Biologics Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
iNtRON Biotechnology Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Paratek Pharmaceuticals Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Pfenex Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Protein Potential LLC Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
ProThera Biologics Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Q BioMed Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Soligenix Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tetraphase Pharmaceuticals Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vast Therapeutics Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
Venomyx Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details
VLP Biotech Inc Anthrax Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. ANTHRAX DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. ANTHRAX PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts